Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Surgical stress induces an amplified inflammatory response in patients with type 2 diabetes.

Lin E, Gletsu-Miller N.

ISRN Obes. 2013 Jan 21;2013:910586. doi: 10.1155/2013/910586. eCollection 2013.

2.

Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.

Immonen H, Hannukainen JC, Iozzo P, Soinio M, Salminen P, Saunavaara V, Borra R, Parkkola R, Mari A, Lehtimäki T, Pham T, Laine J, Kärjä V, Pihlajamäki J, Nelimarkka L, Nuutila P.

J Hepatol. 2014 Feb;60(2):377-83. doi: 10.1016/j.jhep.2013.09.012. Epub 2013 Sep 20.

PMID:
24060855
3.

Bariatric surgery: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(1):1-148. Epub 2005 Jan 1.

4.

The effects of gastric surgery on systemic ghrelin levels in the morbidly obese.

Lin E, Gletsu N, Fugate K, McClusky D, Gu LH, Zhu JL, Ramshaw BJ, Papanicolaou DA, Ziegler TR, Smith CD.

Arch Surg. 2004 Jul;139(7):780-4.

PMID:
15249413
5.

Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus.

Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D.

Ann Surg. 2003 Oct;238(4):467-84; discussion 84-5.

6.

Gastric electrical stimulation: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(16):1-79. Epub 2006 Aug 1.

7.

Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents.

Inge TH, Miyano G, Bean J, Helmrath M, Courcoulas A, Harmon CM, Chen MK, Wilson K, Daniels SR, Garcia VF, Brandt ML, Dolan LM.

Pediatrics. 2009 Jan;123(1):214-22. doi: 10.1542/peds.2008-0522.

PMID:
19117885
8.

Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass.

Catalán V, Gómez-Ambrosi J, Ramirez B, Rotellar F, Pastor C, Silva C, Rodríguez A, Gil MJ, Cienfuegos JA, Frühbeck G.

Obes Surg. 2007 Nov;17(11):1464-74.

PMID:
18219773
9.
10.

Impact of laparoscopic Roux-en-Y gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women.

Iannelli A, Anty R, Piche T, Dahman M, Gual P, Tran A, Gugenheim J.

Obes Surg. 2009 May;19(5):577-82. doi: 10.1007/s11695-008-9764-8. Epub 2008 Nov 19.

PMID:
19018603
11.

IL-34 is associated with obesity, chronic inflammation, and insulin resistance.

Chang EJ, Lee SK, Song YS, Jang YJ, Park HS, Hong JP, Ko AR, Kim DY, Kim JH, Lee YJ, Heo YS.

J Clin Endocrinol Metab. 2014 Jul;99(7):E1263-71. doi: 10.1210/jc.2013-4409. Epub 2014 Apr 8.

PMID:
24712570
12.
13.

Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study.

Whitson BA, Leslie DB, Kellogg TA, Maddaus MA, Buchwald H, Billington CJ, Ikramuddin S.

J Surg Res. 2007 Oct;142(2):295-300. Epub 2007 Jul 19.

PMID:
17640666
14.

Surgery for weight loss in adults.

Colquitt JL, Pickett K, Loveman E, Frampton GK.

Cochrane Database Syst Rev. 2014 Aug 8;(8):CD003641. doi: 10.1002/14651858.CD003641.pub4. Review.

PMID:
25105982
15.

Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes.

Camastra S, Gastaldelli A, Mari A, Bonuccelli S, Scartabelli G, Frascerra S, Baldi S, Nannipieri M, Rebelos E, Anselmino M, Muscelli E, Ferrannini E.

Diabetologia. 2011 Aug;54(8):2093-102. doi: 10.1007/s00125-011-2193-6. Epub 2011 May 26.

PMID:
21614570
16.

Effects of laparoscopic Roux-en-Y gastric bypass on glucose-6 phosphate dehydrogenase activity in obese type 2 diabetics.

Schneider AM, Rawat D, Weinstein LS, Gupte SA, Richards WO.

Surg Endosc. 2012 Mar;26(3):823-30. doi: 10.1007/s00464-011-1959-8. Epub 2011 Nov 15.

PMID:
22083321
17.

Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects.

Romero F, Nicolau J, Flores L, Casamitjana R, Ibarzabal A, Lacy A, Vidal J.

Surg Endosc. 2012 Aug;26(8):2231-9. doi: 10.1007/s00464-012-2166-y.

PMID:
22302537
18.

[Laparoscopic Roux-en-Y gastric bypass surgery for morbid obesity. Experience at the Nacional de Ciencias Médicas y Nutrición Salvador Zubirán].

Romero-Lbargüengoitia ME, Lerman-Garber I, Herrera-Hernández MF, Pablo-Pantoja J, Sierra-Salazar M, López-Rosales F, Zamora-Barrón M, Vargas-Martínez A, García-García E.

Rev Invest Clin. 2009 May-Jun;61(3):186-93. Spanish.

PMID:
19736806
19.

Anatomic findings and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic conversion to Roux-en-Y gastric bypass.

Kellogg TA, Andrade R, Maddaus M, Slusarek B, Buchwald H, Ikramuddin S.

Surg Obes Relat Dis. 2007 Jan-Feb;3(1):52-7; discussion 58-9. Epub 2006 Nov 20.

PMID:
17116426
20.

Evaluation of the biochemical, inflammatory and oxidative profile of obese patients given clinical treatment and bariatric surgery.

Schmatz R, Bitencourt MR, Patias LD, Beck M, da C Alvarez G, Zanini D, Gutierres JM, Diehl LN, Pereira LB, Leal CA, Duarte MF, Schetinger MR, Morsch VM.

Clin Chim Acta. 2017 Feb;465:72-79. doi: 10.1016/j.cca.2016.12.012. Epub 2016 Dec 14.

PMID:
27986549

Supplemental Content

Support Center